- Q4 2023 Elutia Inc Earnings Call TranscriptMar 07, 2024$3.59 (+1.70%)Earnings
- Q3 2023 Elutia Inc Earnings Call TranscriptNov 13, 2023$1.46 (-0.68%)Earnings
- Elutia Inc at Cantor Fitzgerald Global Healthcare Conference TranscriptSep 27, 2023
- Q2 2023 Aziyo Biologics Inc Earnings Call TranscriptAug 14, 2023$1.34 (-2.90%)Earnings
- Q1 2023 Aziyo Biologics Inc Earnings Call TranscriptMay 10, 2023$2.47 (+4.22%)Earnings
- Q4 2022 Aziyo Biologics Inc Earnings Call TranscriptMar 22, 2023$1.19 (-2.46%)Earnings
- Aziyo Biologics Inc at Cowen Health Care Conference TranscriptMar 06, 2023
- Q3 2022 Aziyo Biologics Inc Earnings Call TranscriptNov 14, 2022$8.1 (+1.12%)Earnings
- Q2 2022 Aziyo Biologics Inc Earnings Call TranscriptAug 11, 2022$6.45Earnings
- Q1 2022 Aziyo Biologics Inc Earnings Call TranscriptMay 09, 2022$6.42 (-2.73%)Earnings
- Q4 2021 Aziyo Biologics Inc Earnings Call TranscriptMar 03, 2022$6 (-10.28%)Earnings
- Q3 2021 Aziyo Biologics Inc Earnings Call TranscriptNov 09, 2021$6.2 (-1.59%)Earnings
- Q2 2021 Aziyo Biologics Inc Earnings Call TranscriptAug 09, 2021$8.3 (+2.22%)Earnings
- Aziyo Biologics Inc Annual Shareholders Meeting TranscriptJun 07, 2021
- Q1 2021 Aziyo Biologics Inc Earnings Call TranscriptMay 04, 2021$9.51 (-1.55%)Earnings
- Aziyo Biologics Inc at Cowen Healthcare Conference (Virtual) TranscriptMar 04, 2021
- Q4 2020 Aziyo Biologics Inc Earnings Call TranscriptMar 01, 2021$15.51 (-2.58%)Earnings
- Q3 2020 Aziyo Biologics Inc Earnings Call TranscriptNov 19, 2020$12.28 (-5.47%)Earnings
Q4 2021 Aziyo Biologics Inc Earnings Call Transcript
Hello, and thank you for standing by. Welcome to Aziyo Biologics Fourth Quarter and Full Year 2021 Earnings Conference Call. (Operator Instructions)
I would now like to hand the conference over to Leigh Salvo with Investor Relations. Please go ahead.
Thank you, and thank you all for participating in today's call. Joining me are Ron Lloyd, Chief Executive Officer; and Matt Ferguson, Chief Financial Officer. Earlier today, Aziyo released financial results for the quarter and full year ended December 31, 2021. A copy of the press release is available on the company's website.
Before we begin, I'd like to remind you that management will make statements during this call that include forward-looking statements within the meaning of federal securities laws, which are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Any statements contained in this call that do not relate to matters of historical facts or relate to expectations or predictions of future events
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
![](https://static.gurufocus.com/material/money-back-guarantee.png)
![](https://static.gurufocus.com/trust_rating.png)
![](https://static.gurufocus.com/trust.png)